Publications by authors named "T Iglesias"

Article Synopsis
  • The study investigates the role of protein kinase D2 (PKD2) in regulating insulin signaling and metabolic homeostasis in the liver, as its functions are not yet fully understood.
  • Using various experimental methods, including PKD2 overexpression and specific gene depletion in mouse models, researchers assessed how PKD2 affects insulin responses and glucose metabolism.
  • Findings reveal that PKD2 inhibits insulin signaling by modifying the phosphorylation of insulin receptor substrate 1 (IRS1), and suggest that PKD2 could be targeted therapeutically to combat hepatic insulin resistance.
View Article and Find Full Text PDF

Lymphoid tumor patients often exhibit resistance to standard therapies or experience relapse post-remission. Relapse is driven by Tumor Initiating Cells (TICs), a subset of tumor cells capable of regrowing the tumor and highly resistant to therapy. Growing cells in 3D gels is a method to discern tumorigenic cells because it strongly correlates with tumorigenicity.

View Article and Find Full Text PDF

Purpose: Spastic paraplegia, intellectual disability, nystagmus, and obesity syndrome (SINO) is a rare autosomal dominant condition caused by heterozygous variants in KIDINS220. A total of 12 individuals are reported, comprising 8 with SINO and 4 with an autosomal recessive condition attributed to biallelic KIDINS220 variants.

Methods: In our international cohort, we have included 14 individuals, carrying 13 novel pathogenic KIDINS220 variants in heterozygous form.

View Article and Find Full Text PDF

The lack of sensitive diagnostic methods to detect subsp. (Map) subclinical infections has hindered the control of paratuberculosis (PTB). The serum proteomic profiles of naturally infected cows presenting focal and diffuse pathological forms of PTB and negative controls ( = 4 per group) were analyzed using TMT-6plex quantitative proteomics.

View Article and Find Full Text PDF

Protein kinase D (PKD) family members play controversial roles in prostate cancer (PC). Thus, PKD1 is nearly absent in advanced tumours, where PKD2 and PKD3 are upregulated. Additionally, consequences of activation of these kinases on PC progression remain largely unclear.

View Article and Find Full Text PDF